Tactile Systems Technology (NASDAQ:TCMD) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPS

Tactile Systems Technology (NASDAQ:TCMD) posted its earnings results on Sunday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.15) by $0.08, Fidelity Earnings reports. Tactile Systems Technology had a negative net margin of 4.57% and a positive return on equity of 1.37%.

Tactile Systems Technology stock traded down $5.49 during mid-day trading on Tuesday, reaching $53.15. The company’s stock had a trading volume of 11,973 shares, compared to its average volume of 159,589. The business has a 50 day moving average price of $54.45 and a 200-day moving average price of $48.66. Tactile Systems Technology has a twelve month low of $30.31 and a twelve month high of $64.53. The firm has a market cap of $1.04 billion, a price-to-earnings ratio of -117.62, a PEG ratio of 10.36 and a beta of 1.69.

Several equities research analysts have issued reports on TCMD shares. TheStreet upgraded shares of Tactile Systems Technology from a “d+” rating to a “c” rating in a research note on Tuesday, February 23rd. BTIG Research upped their price target on shares of Tactile Systems Technology from $51.00 to $60.00 and gave the stock an “in-line” rating in a research report on Monday, January 25th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $59.00.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.

Recommended Story: Stop Order

Earnings History for Tactile Systems Technology (NASDAQ:TCMD)

Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.